1. Market Research
  2. > Pathology Industry
  3. > All premium reports

Publication dates

1-10 of about 2 500 reports for Phase Iii Clinical Trial

Purchase Reports From Reputable Market Research Publishers

Pharmacovigilance Market Analysis By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial), By Type Of Service Providers (In House, Contract Outsourcing) And Segment Forecasts To 2020

Pharmacovigilance Market Analysis By Clinical Trial Phases Preclinical Studies Phase I 1 Phase II 2 Phase III 3 Phase IV 4 Trial By Type Of Service Providers In House Contract Outsourcing And Segment Forecasts To 2020

  • $ 4 700
  • Industry report
  • February 2015
  • by Grand View Research

Global pharmacovigilance market is expected to reach USD 5 51 billion by 2020 Increasing incidence rates of adverse drug reaction and the introduction of stringent drug safety regulations are some key

Evolocumab (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

Evolocumab Acute Coronary Syndrome Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • July 2014
  • by Global Data

Evolocumab Acute Coronary Syndrome Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report Evolocumab Acute Coronary Syndrome Forecast

Pharmacovigilance Market: Global Industry Analysis and Opportunity Assessment, 2015 - 2020

Pharmacovigilance Market Global Industry Analysis and Opportunity Assessment 2015 2020

  • $ 5 000
  • Industry report
  • December 2015
  • by Future Market Insight Global & Consulting Pvt Ltd

Future Market Insights offers a 6 year forecast of the global pharmacovigilance market between 2015 and 2020 In terms of value the market is expand at a CAGR of 14 2 during the forecast period This

Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2014

Dysbetalipoproteinemia Type III Hyperlipoproteinemia Global Clinical Trials Review H1 2014

  • $ 2 500
  • Industry report
  • May 2014
  • by Global Data

Dysbetalipoproteinemia Type III Hyperlipoproteinemia Global Clinical Trials Review H1 2014 Summary GlobalData s clinical trial report Dysbetalipoproteinemia Type III Hyperlipoproteinemia Global

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Global Clinical Trials Review, H1, 2014

Mucopolysaccharidosis III MPS III Sanfilippo Syndrome Global Clinical Trials Review H1 2014

  • $ 2 500
  • Industry report
  • May 2014
  • by Global Data

Mucopolysaccharidosis III MPS III Sanfilippo Syndrome Global Clinical Trials Review H1 2014 Summary GlobalData s clinical trial report Mucopolysaccharidosis III MPS III Sanfilippo Syndrome

PCSK9 and Other Novel Hypercholesterolemia Drugs Market, 2014 - 2024

PCSK9 and Other Novel Hypercholesterolemia Drugs Market 2014 2024

  • $ 1 899
  • Industry report
  • September 2014
  • by Roots Analysis Private Ltd.

INTRODUCTION Worldwide statistics indicate that there is a high cholesterol burden despite the presence of many cholesterol lowering drugs in the market Out of all the available options statins have

Oral Oncolytics Series: Leukemia, 2014 - 2024

Oral Oncolytics Series Leukemia 2014 2024

  • $ 1 899
  • Industry report
  • May 2014
  • by Roots Analysis Private Ltd.

INTRODUCTION Targeted therapeutics is fast emerging as the key focus area in biopharmaceutical industry Oral targeted therapeutics has attracted many drug developers due to the ease of administration

eClinical Solutions Market by Product, Delivery Mode, Clinical Trial Phases, End User - Global Forecast to 2020

eClinical Solutions Market by Product Delivery Mode Clinical Trial Phases End User Global Forecast to 2020

  • $ 4 650
  • Industry report
  • February 2016
  • by MarketsandMarkets

The global eClinical solutions market is estimated to grow at a high CAGR of 12 1 from 2015 to 2020 Although developed regions such as North America and Europe held large shares in the eClinical solutions

Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

Pharmacovigilance Market Global Industry Analysis Size Share Growth Trends and Forecast 2014 2020

  • $ 4 795
  • Industry report
  • March 2015
  • by Transparency Market Research

Intensifying regulatory expectations tougher inspection system and instant need for patient reporting boost the adoption rate of pharmacovigilance among pharmaceutical companies Rise in the prevalence

Worldwide - Hepatitis C Drugs Market & Pipeline Drugs Analysis to 2019

Worldwide Hepatitis C Drugs Market Pipeline Drugs Analysis to 2019

  • $ 900
  • Industry report
  • October 2014
  • by Igate Research

Hepatitis C hep C is a viral disease caused by the Hepatitis C virus HCV and transmitted by blood primarily in health care settings It can progressively damage the liver and if left untreated

About 2 100 reports for Phase Iii Clinical Trial

Download Unlimited Documents from Trusted Public Sources

Cerus Corporation Annual Report 2014

  • January 2014
    142 pages
  • Blood Supply  

  • United States  

View report >

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.